Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study. (2022)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2022.100478
PubMed Identifier: 36105885
Publication URI: http://europepmc.org/abstract/MED/36105885
Type: Journal Article/Review
Volume: 21
Parent Publication: The Lancet regional health. Europe
ISSN: 2666-7762